$67.82
Price
$8.0B
Market Cap
26.5
P/E Ratio
6.9
Forward P/E
$2.56
EPS (TTM)
—
Dividend Yield
$143M
Cash
$2.1B
Total Debt
118M
Shares Out
$47.50
$82.22
52-Week Range
Institutional Ownership of HALOZYME THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for HALOZYME THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for HALOZYME THERAPEUTICS INC
6 Months Insider Sentiment
Buy $0
Sell $5.9M
0
Buys
16
Sells
-5.9M
Net
2
Grants
Largest
$1.4M
Torley
$893K
Torley
$802K
Torley
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 05, 2026 | Bernadette Connaughton | Director | SELL | 2.0K | $70.25 | $140K |
| Jan 03, 2026 | Mark Howard Snyder | SVP, CHIEF LEGAL OFFICER | EXERCISE | 7.6K | — | — |
| Jan 02, 2026 | James Paul Lang | Director | GRANT | 889 | — | — |
| Dec 01, 2025 | Helen Torley | PRESIDENT AND CEO | SELL | 5.4K | $69.44 | $375K |
| Dec 01, 2025 | Helen Torley | PRESIDENT AND CEO | SELL | 500 | $70.36 | $35K |
| Dec 01, 2025 | Helen Torley | PRESIDENT AND CEO | SELL | 261 | $71.60 | $19K |
| Dec 01, 2025 | Helen Torley | PRESIDENT AND CEO | EXERCISE | 16.6K | $8.11 | $134K |
| Dec 01, 2025 | Bernadette Connaughton | Director | SELL | 829 | $71.60 | $59K |
| Dec 01, 2025 | Helen Torley | PRESIDENT AND CEO | SELL | 10.4K | $68.51 | $713K |
| Nov 26, 2025 | Helen Torley | PRESIDENT AND CEO | GRANT | 25.0K | — | — |
| Nov 12, 2025 | Helen Torley | PRESIDENT AND CEO | EXERCISE | 20.0K | $8.11 | $162K |
| Nov 12, 2025 | Helen Torley | PRESIDENT AND CEO | SELL | 498 | $71.67 | $36K |
| Nov 12, 2025 | Helen Torley | PRESIDENT AND CEO | SELL | 6.8K | $71.09 | $482K |
| Nov 12, 2025 | Helen Torley | PRESIDENT AND CEO | SELL | 12.7K | $70.22 | $893K |
| Nov 11, 2025 | Helen Torley | PRESIDENT AND CEO | EXERCISE | 20.0K | $8.11 | $162K |
| Nov 11, 2025 | Helen Torley | PRESIDENT AND CEO | SELL | 11.5K | $69.73 | $802K |
| Nov 11, 2025 | Helen Torley | PRESIDENT AND CEO | SELL | 4.5K | $67.89 | $306K |
| Nov 11, 2025 | Helen Torley | PRESIDENT AND CEO | SELL | 4.0K | $68.80 | $275K |
| Nov 10, 2025 | Helen Torley | PRESIDENT AND CEO | EXERCISE | 20.0K | $8.11 | $162K |
| Nov 10, 2025 | Helen Torley | PRESIDENT AND CEO | SELL | 19.9K | $68.71 | $1.4M |
| Nov 10, 2025 | Helen Torley | PRESIDENT AND CEO | SELL | 100 | $69.30 | $7K |
| Nov 10, 2025 | Bernadette Connaughton | Director | SELL | 2.0K | $68.48 | $137K |
| Nov 01, 2025 | Cortney Caudill | SVP, CHIEF OPERATING OFFICER | SELL | 4.3K | $65.19 | $278K |
| Nov 01, 2025 | Cortney Caudill | SVP, CHIEF OPERATING OFFICER | EXERCISE | 9.3K | — | — |